Bard Announces Third Quarter Results
十月 25, 2017
MURRAY HILL, N.J.--(BUSINESS WIRE)--Oct. 25, 2017--
C. R. Bard, Inc. (NYSE: BCR) today reported 2017 third quarter financial
results. The company has included supplemental financial data... Read More
Bard Declares Quarterly Dividend
十月 11, 2017
MURRAY HILL, N.J.--(BUSINESS WIRE)--Oct. 11, 2017--
The Board of Directors of C. R. Bard, Inc. (NYSE-BCR) today declared a
regular quarterly dividend of 26 cents per share on Bard's... Read More
C. R. Bard Receives FDA Premarket Approval of the LUTONIX® 035 Drug Coated Balloon as the First and Only DCB for the Treatment of Patients with Dysfunctional AV Fistulae
八月 28, 2017
New Option to Preserve Vascular Access and Help Hemodialysis Patients
Extend Time Between Reinterventions
MURRAY HILL, N.J.--(BUSINESS WIRE)--Aug. 28, 2017--
C. R. Bard, Inc.... Read More
